Fatal Left Ventricular Thrombosis in an Infant ReceivingExtracorporeal Membrane Oxygenation Support -A Case Report-
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Thromboembolism in patients receiving extracorporeal membrane oxygenation (ECMO) support is a feared complication. Systemic anticoagulation during ECMO in patients with a massively dilated left ventricle (LV) and decreased LV systolic function is still debated. Hearin, we report a case of a 5-month old infant on ECMO support who had fatal thrombus formation in the massively dilated LV and a consequent thromboembolic event.
Abstract
Thromboembolism in patients receiving extracorporeal membrane oxygenation (ECMO) support is a feared complication. Systemic anticoagulation during ECMO in patients with a massively dilated left ventricle (LV) and decreased LV systolic function is still debated. Hearin, we report a case of a 5-month old infant on ECMO support who had fatal thrombus formation in the massively dilated LV and a consequent thromboembolic event.
참고문헌 (14)
- 제형곤, "중환자실에서 체외막형 산소섭취의 현재와 미래", 대한중환자의학회지, 26(2), pp.51~56 (2011), 대한중환자의학회
- Fries D, "Coagulation monitoring and management of anticoagulation during cardiac assist device support", Ann Thorac Surg, 76, pp.1593~1597 (2003)
- Spanier T, "Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices", J Thorac Cardiovasc Surg, 112, pp.1090~1097 (1996)
- Lip GY, "ESC Task Force: Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis", Eur J Heart Fail, 14, pp.681~695 (2012)
- Bakalli A, "Prevalence of left chamber cardiac thrombi in patients with dilated left ventricle at sinus rhythm: the role of transesophageal echocardiography", J Clin Ultrasound, 41, pp.38~45 (2013)
- Teele SA, "Management and outcomes in pediatric patients presenting with acute fulminant myocarditis", J Pediatr, 158, pp.638~643 (2011)
- Messika-Zeitoun D, "Cardiopulmonary exercise testing determination of functional capacity in mitral regurgitation: physiologic and outcome implications", J Am Coll Cardiol, 47, pp.2521~2527 (2006)
- Ward KE, "Transseptal decompression of the left heart during ECMO for severe myocarditis", Ann Thorac Surg, 59, pp.749~751 (1995)
- Jouan J, "Successful left ventricular decompression following peripheral extracorporeal membrane oxygenation by percutaneous placement of a micro-axial flow pump", J Heart Lung Transplant, 29, pp.135~136 (2010)
- Muntean W, "Coagulation and anticoagulation in extracorporeal membrane oxygenation", Artif Organs, 23, pp.979~983 (1999)
- De Waele JJ, "The use of the activated clotting time for monitoring heparin therapy in critically ill patients", Intensive Care Med, 29, pp.325~328 (2003)
- Koster A, "The plasma supplemented modified activated clotting time for monitoring of heparinization during cardiopulmonary bypass : a pilot investigation", Anesth Analg, 95, pp.26~30 (2002)
- Raymond PD, "Heparin monitoring during cardiac surgery. Part 2: Calculating the overestimation of heparin by the activated clotting time", Perfusion, 18, pp.277~281 (2003)
- Nagaya M, "Application of a new anticoagulant (Nafamostat Mesilate) to control hemorrhagic complications during extracorporeal membrane oxygenation--a preliminary report", J Pediatr Surg, 32, pp.531~535 (1997)